Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodefi...
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
About this item
Full title
Author / Creator
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
Antibody deficiency is the most frequently encountered primary immunodeficiency disease (PIDD) and patients who lack the ability to make functional immunoglobulin require life-long replacement therapy to prevent serious bacterial infections. Human serum immunoglobulin manufactured from pools of donated plasma can be administered intramuscularly, in...
Alternative Titles
Full title
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8b9b2eb56e544a9fa2b9216cc9ea2798
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8b9b2eb56e544a9fa2b9216cc9ea2798
Other Identifiers
ISSN
1178-203X,1176-6336
E-ISSN
1178-203X
DOI
10.2147/TCRM.S4353
